Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2025 1.158M
June 30, 2024 0.9818M
June 30, 2023 0.9924M
June 30, 2022 0.6665M
June 30, 2021 0.6243M
June 30, 2020 0.8861M
June 30, 2019 0.5053M
June 30, 2018 0.4564M
June 30, 2017 0.4642M
June 30, 2016 0.4783M
June 30, 2015 0.4929M
June 30, 2014 0.4711M
June 30, 2013 0.6303M
June 30, 2012 0.6647M
Date Value
June 30, 2011 0.825M
June 30, 2010 0.5294M
June 30, 2009 0.7378M
June 30, 2008 0.7579M
June 30, 2007 1.312M
June 30, 2006 1.106M
June 30, 2005 1.143M
June 30, 2004 1.319M
June 30, 2003 1.235M
June 30, 2002 2.271M
June 30, 2001 3.215M
June 30, 2000 1.694M
June 30, 1999 0.9412M
June 30, 1998 0.897M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
RxSight, Inc. 38.55M
Abbott Laboratories 2.889B
Align Technology, Inc. 369.91M
AngioDynamics, Inc. 29.45M
Accuray, Inc. 37.75M